Hostname: page-component-76fb5796d-vvkck Total loading time: 0 Render date: 2024-04-27T04:28:24.045Z Has data issue: false hasContentIssue false

Properdin and the defence of burns against infection

Published online by Cambridge University Press:  15 May 2009

E. J. L. Lowbury
Affiliation:
The Medical Research Council Industrial Injuries and Burns Unit, Birmingham Accident Hospital
C. R. Ricketts
Affiliation:
The Medical Research Council Industrial Injuries and Burns Unit, Birmingham Accident Hospital
M. Hall
Affiliation:
The Medical Research Council Industrial Injuries and Burns Unit, Birmingham Accident Hospital
L. Hurst
Affiliation:
The Medical Research Council Industrial Injuries and Burns Unit, Birmingham Accident Hospital
H. A. Lilly
Affiliation:
The Medical Research Council Industrial Injuries and Burns Unit, Birmingham Accident Hospital
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Treatment of serum with the insoluble polysaccharide residue of yeast cells (zymosan) has been shown (a) to decrease the bactericidal power of serum for certain bacteria; (b) to remove from some sera a factor essential to the interaction of zymosan with the third component of complement. The adsorbed protein (properdin) was eluted from zymosan and found to contain α2, β and some γ globulins. It was shown to restore partially the normal characteristics to treated serum (RP).

Properdin levels have been estimated in the sera of eighteen burned patients and in twelve normal subjects. There was evidence of a reduced level in the patients' sera. The limitations of the assay method are discussed.

Bactericidal activity of normal serum containing properdin was tested against nineteen Gram-negative bacilli isolated from burns. Ps. pyocyanea, Proteus and Klebsiella, which are commonly found in burns, were with one exception resistant or slightly sensitive to the bactericidal action of this serum. Bact. coli, which is uncommon in burns, was usually highly sensitive.

From our preliminary studies reported here it would seem that the properdin system cannot be expected to kill the flora in established infections of burns, and properdin is therefore unlikely to prove useful as a therapeutic agent. However, it probably has an important role as one of the defence mechanisms of uninfected tissues.

We wish to thank Dr Derrick Rowley and Dr A. C. Wardlaw for helpful discussions, and Dr W. Weiner for his advice and co-operation. We are grateful to Miss Stella Baar, F.R.I.C., for N and P analyses.

Type
Research Article
Copyright
Copyright © Cambridge University Press 1957

References

REFERENCES

Fine, J. (1955). Ann. Surg. 142, 361.CrossRefGoogle Scholar
Foster, A. (1953). J. chem. Soc. p. 982.CrossRefGoogle Scholar
Lowbuby, E. J. L., Topley, E. & Hood, A. M. (1952). Lancet, 1, 1036.CrossRefGoogle Scholar
Miles, A. A., Misra, S. S. & Irwin, J. O. (1938). J. Hyg., Camb., 38, 732.Google Scholar
Pillemer, L. (1955). Trans. N.Y. Acad. Sci. (Ser. n), 17, 526.CrossRefGoogle Scholar
Pillemeb, L., Blum, L., Lepow, I. H., Ross, O. A., Todd, E. W. & Wabdlaw, A. C. (1954). Science, 120, 279.CrossRefGoogle Scholar
Pillemer, L., Blum, L., Lepow, I. H., Wurz, L. & Todd, E. W. (1956). J. exp. Med. 103, 1.CrossRefGoogle Scholar
Pillemer, L. & Ecker, E. E. (1941). J. biol. Chem. 137, 139.CrossRefGoogle Scholar
Pillemer, L. & Ross, O. A. (1955). Science, 121, 732.CrossRefGoogle Scholar
Pillemer, L., Schoenberg, M. D., Blum, L. & Wurz, L. (1955). Science, 122, 545.CrossRefGoogle Scholar
Rowley, D. (1955). Lancet, 1, 232.CrossRefGoogle Scholar
Trevelyan, W. E. & Harbison, J. S. (1952). Biochem. J. 50, 298.CrossRefGoogle Scholar
Wabdlaw, A. C. & Pillemer, L. (1956). J. exp. Med. 103, 553.CrossRefGoogle Scholar